Evaluating antibiotic stewardship programs in patients with bacteremia using administrative data: a cohort study
- 410 Downloads
When introducing new antibiotic guidelines for empirical treatment of bacteremia, it is imperative to evaluate the performance of the new guideline. We examined the utility of administrative data to evaluate the effect of new antibiotic guidelines and the prognostic impact of appropriate empirical treatment. We categorized 2,008 adult patients diagnosed with bacteremia between 2010 and 2012 according to whether they received cephalosporins or fluoroquinolones (old regimen) or not (new regimen). We used administrative data to extract individual level data on mortality, readmission, and appropriateness of treatment, and computed adjusted hazard ratios (HRs) and 95 % confidence intervals (CIs) for 30-day mortality and post-discharge readmission by regimen and appropriateness of treatment. In total, 945 (47.1 %) were treated by the old regimen and 1,063 (52.9 %) by the new. The median length of stay (8 days) did not differ by regimen and neither did the proportion of those receiving appropriate empirical treatment (84.1 % vs. 85.5 %). However, fewer patients with the new regimen were admitted to the intensive care unit (ICU; 3.8 % vs. 12.0 %) and they had lower 30-day mortality (16.4 % vs. 23.4 %). The adjusted 30-day mortality HR for appropriate versus inappropriate treatment was 0.79 (95 % CI 0.62–1.01) and 0.83 (95 % CI 0.66–1.05) for the new versus the old regimen. The HR for 30-day readmission for appropriate versus inappropriate treatment was 0.91 (95 % CI 0.73–1.13) and 1.05 (95 % CI 0.87–1.25) for the new versus the old regimen. This study demonstrates that administrative data can be useful for evaluating the effect and quality of new bacteremia treatment guidelines.
Conflict of interest
All authors report no conflict of interest relevant to this article.
- 1.van der Velden LBJ, Tromp M, Bleeker-Rovers CP, Hulscher M, Kullberg BJ, Mouton JW et al (2012) Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis 31:1561–1568. doi:10.1007/s10096-011-1478-5 PubMedCentralPubMedCrossRefGoogle Scholar
- 5.Gradel KO, Knudsen JD, Arpi M, Østergaard C, Schønheyder HC, Søgaard M (2012) Classification of positive blood cultures: computer algorithms versus physicians’ assessment—development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases. BMC Med Res Methodol 12:139. doi:10.1186/1471-2288-12-139 PubMedCentralPubMedCrossRefGoogle Scholar
- 6.Hota B, Lin M, Doherty JA, Borlawsky T, Woeltje K, Stevenson K et al (2010) Formulation of a model for automating infection surveillance: algorithmic detection of central-line associated bloodstream infection. J Am Med Inform Assoc 17:42–48. doi:10.1197/jamia.M3196 PubMedCentralPubMedCrossRefGoogle Scholar
- 10.Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN et al (2008) Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis 8:116. doi:10.1186/1471-2334-8-116 PubMedCentralPubMedCrossRefGoogle Scholar
- 12.Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A et al (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63:568–574. doi:10.1093/jac/dkn514 PubMedCrossRefGoogle Scholar
- 13.Drye EE, Normand S-LT, Wang Y, Ross JS, Schreiner GC, Han L et al (2012) Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med 156:19–26. doi:10.7326/0003-4819-156-1-201201030-00004 PubMedCentralPubMedCrossRefGoogle Scholar
- 15.Freundlich M, Thomsen RW, Pedersen L, West H, Schønheyder HC (2007) Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study. J Antimicrob Chemother 60:1115–1123. doi:10.1093/Jac/Dkm354 PubMedCrossRefGoogle Scholar
- 19.Rothman KJ (2012) Epidemiology: an introduction, 2nd edn. Oxford University Press, New YorkGoogle Scholar
- 22.Rhee J-Y, Kwon KT, Ki HK, Shin SY, Jung DS, Chung D-R et al (2009) Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31:146–150PubMedCrossRefGoogle Scholar
- 23.Feldman C, Alanee S, Yu VL, Richards GA, Ortqvist A, Rello J et al (2009) Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care. Clin Microbiol Infect 15:850–857. doi:10.1111/j.1469-0691.2009.02901.x PubMedCrossRefGoogle Scholar